In hepatocellular carcinoma (HCC), overexpression of glutamine synthase (GS) correlates with Wnt/β-catenin activation, indicating a link between glutamine metabolism and tumor progression (Wong et al., 2020). The gene discussed is GLUL; the disease is neoplasm.